Pfizer is getting another COVID-19 sales boost
Pfizer
In This Story PFE -1.52% FDS +0.49% Pfizer ( PFE -1.52% ) reported its third-quarter earnings on Tuesday, beating Wall Street expectations and its raising its full-year guidance thanks to a surge in demand for the pharma giant’s COVID-19 medications. Suggested Reading This rare dime is worth $499,999.90 more than usual Elon Musk says there's still a decent chance AI could go bad Boeing's stock sale went surprisingly well Audiences will be major beneficiaries of AI in the media industry, CEO
din zilele anterioare